Tadashi Nomizu
Koriyama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Analysis of the conditions for applying BRCA genetic testing to women with breast cancer using the Japanese HBOC consortium and the Japanese organization of hereditary breast and ovarian cancer (JOHBOC) registry project database.
Journal: Breast cancer (Tokyo, Japan)
Published: December 18, 2024
TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohorts.
Journal: Translational oncology
Published: May 04, 2024
Predictive modeling for the germline pathogenic variant of the APC gene in patients with adenomatous polyposis: proposing a new APC score.
Journal: Surgery today
Published: March 08, 2024
Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: March 17, 2023
Correction to: APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients.
Journal: International journal of clinical oncology
Published: December 20, 2021
Application of targeted nanopore sequencing for the screening and determination of structural variants in patients with Lynch syndrome.
Journal: Journal of human genetics
Published: February 22, 2021
APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients.
Journal: International journal of clinical oncology
Published: December 14, 2020
TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patients.
Journal: Breast cancer (Tokyo, Japan)
Published: December 12, 2020
A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: July 28, 2020
The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database.
Journal: Journal of human genetics
Published: July 13, 2020
Intracellular localization of CK2α as a prognostic factor in invasive breast carcinomas.
Journal: Cancer science
Published: July 03, 2020
Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration.
Journal: Journal of human genetics
Published: May 08, 2020
Last Updated: 09/26/2026